NO20003315L - Indol-derivater anvendelige bl a for behandling av osteoporose - Google Patents

Indol-derivater anvendelige bl a for behandling av osteoporose

Info

Publication number
NO20003315L
NO20003315L NO20003315A NO20003315A NO20003315L NO 20003315 L NO20003315 L NO 20003315L NO 20003315 A NO20003315 A NO 20003315A NO 20003315 A NO20003315 A NO 20003315A NO 20003315 L NO20003315 L NO 20003315L
Authority
NO
Norway
Prior art keywords
osteoporosis
treatment
inter alia
indole derivatives
derivatives useful
Prior art date
Application number
NO20003315A
Other languages
English (en)
Other versions
NO20003315D0 (no
NO320272B1 (no
Inventor
Stefania Gagliardi
Pietro Novella
Guy Marguerite Marie Ge Nadler
Original Assignee
Smithkline Beecham Lab
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Lab, Smithkline Beecham Spa filed Critical Smithkline Beecham Lab
Publication of NO20003315L publication Critical patent/NO20003315L/no
Publication of NO20003315D0 publication Critical patent/NO20003315D0/no
Publication of NO320272B1 publication Critical patent/NO320272B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003315A 1997-12-24 2000-06-23 Indolderivater, deres fremstilling og formulering i farmasoytiske preparater anvendbare for behandling av osteoporose og beslektede sykdommer NO320272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403154 1997-12-24
PCT/EP1998/008561 WO1999033822A1 (en) 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis

Publications (3)

Publication Number Publication Date
NO20003315L true NO20003315L (no) 2000-06-23
NO20003315D0 NO20003315D0 (no) 2000-06-23
NO320272B1 NO320272B1 (no) 2005-11-14

Family

ID=8229937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003315A NO320272B1 (no) 1997-12-24 2000-06-23 Indolderivater, deres fremstilling og formulering i farmasoytiske preparater anvendbare for behandling av osteoporose og beslektede sykdommer

Country Status (22)

Country Link
EP (1) EP1042316B1 (no)
JP (1) JP4627881B2 (no)
KR (1) KR20010033528A (no)
CN (1) CN1208333C (no)
AR (1) AR018032A1 (no)
AT (1) ATE288909T1 (no)
AU (1) AU749319B2 (no)
BR (1) BR9814403A (no)
CA (1) CA2315723A1 (no)
CO (1) CO4970811A1 (no)
DE (1) DE69828998T2 (no)
ES (1) ES2236971T3 (no)
HU (1) HUP0100785A3 (no)
IL (1) IL136720A0 (no)
NO (1) NO320272B1 (no)
NZ (1) NZ505060A (no)
PL (1) PL191633B1 (no)
SA (1) SA99200109B1 (no)
SI (1) SI1042316T1 (no)
TR (1) TR200001992T2 (no)
WO (1) WO1999033822A1 (no)
ZA (1) ZA9811758B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) * 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
ES2325477T3 (es) * 2000-03-31 2009-09-07 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indoles sustituidos por fenilo como antagonistas del receptor de histamina h3.
ATE361297T1 (de) 2000-03-31 2007-05-15 Ortho Mcneil Pharm Inc Phenyl-substituierte imidazopyridine
US6872834B2 (en) 2000-03-31 2005-03-29 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted indoles and indazoles
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
US20090142832A1 (en) * 2007-11-29 2009-06-04 James Dalton Indoles, Derivatives, and Analogs Thereof and Uses Therefor
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
US9556146B2 (en) 2014-10-24 2017-01-31 Biotherapeutics, Inc. Lanthionine synthetase C-like 2-based therapeutics
CN111511904A (zh) 2017-11-30 2020-08-07 朗多生物制药股份有限公司 使用羊毛硫氨酸c样蛋白2配体和用其制备的细胞的疗法
WO2021127472A1 (en) 2019-12-20 2021-06-24 Landos Biopharma, Inc. Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3542827B2 (ja) * 1994-07-15 2004-07-14 帝国臓器製薬株式会社 新規な5−置換イソキサゾール−3−カルボン酸アミド誘導体
KR19980701330A (ko) * 1995-01-10 1998-05-15 파올로 비지 골다공증의 치료에 유용한 인돌 유도체(Indole Derivatives Useful in The Treatment of Osteoporosis)
CA2293418A1 (en) * 1997-06-19 1998-12-23 Michael Z. Hoemann Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto

Also Published As

Publication number Publication date
CN1208333C (zh) 2005-06-29
ZA9811758B (en) 2000-06-22
CO4970811A1 (es) 2000-11-07
AU2715499A (en) 1999-07-19
SI1042316T1 (no) 2005-08-31
PL191633B1 (pl) 2006-06-30
HUP0100785A3 (en) 2001-09-28
TR200001992T2 (tr) 2001-01-22
PL341318A1 (en) 2001-04-09
JP4627881B2 (ja) 2011-02-09
NZ505060A (en) 2002-09-27
SA99200109B1 (ar) 2006-09-13
JP2003532616A (ja) 2003-11-05
AU749319B2 (en) 2002-06-20
DE69828998T2 (de) 2006-05-04
KR20010033528A (ko) 2001-04-25
EP1042316B1 (en) 2005-02-09
DE69828998D1 (de) 2005-03-17
IL136720A0 (en) 2001-06-14
CA2315723A1 (en) 1999-07-08
AR018032A1 (es) 2001-10-31
ATE288909T1 (de) 2005-02-15
NO20003315D0 (no) 2000-06-23
WO1999033822A1 (en) 1999-07-08
HUP0100785A2 (hu) 2001-08-28
ES2236971T3 (es) 2005-07-16
NO320272B1 (no) 2005-11-14
CN1299357A (zh) 2001-06-13
BR9814403A (pt) 2000-10-10
EP1042316A1 (en) 2000-10-11
HK1032953A1 (en) 2001-08-10

Similar Documents

Publication Publication Date Title
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
BR9612465A (pt) Compostos heterocíclicos
FI102426B1 (fi) Menetelmä muistin toteuttamiseksi
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
FI102425B1 (fi) Menetelmä muistin toteuttamiseksi
FI972919A0 (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
NO982462L (no) Maling av fyllingsgrad
NO20003315L (no) Indol-derivater anvendelige bl a for behandling av osteoporose
ATA100695A (de) Prothrombin-derivate
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20001387L (no) FremgangsmÕte for syntese av kinolinderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
ATE177102T1 (de) Chromanderivate
DK0725061T3 (da) Substituerede indolderivater
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO974876D0 (no) Fremgangsmåte for fremstilling av en dihydroksyaminoforbindelse
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
ATA45796A (de) Lysin-prolin-derivate